Hong Kong Interactive Media and Services Stock News

China Merchants Land entered these results with the stock down over the past quarter and trading at a very low price-to-sales multiple versus Hong Kong real estate peers. The headline from this half year is not the top line. It is the ongoing drag from losses and the strain this puts on a balance sheet that already struggles to cover interest costs from earnings. H1 2026 revenue of C¥3,857.21m sits against a fresh net loss of C¥226.95m and another loss per share. For you as a shareholder, the...

Haitong Unitrust International Financial Leasing closed at HK$1.01 today after the market digested its Q2 scorecard, a modest price for a stock that screens on a trailing P/E of 6.2x against higher peer multiples. The headline is not a blowout quarter or a collapse in profit. The real story is a valuation gap colliding with a balance sheet that still leans on debt and cash generation that has not fully eased coverage concerns. Short term traders see a cheap financial lessor. Long term holders...

Everest Medicines came into this print under pressure, with the stock down about 16% over the past week and roughly 25% over three months. Yet the headline from H1 2026 is not about collapse. It is about a commercial stage biotech that generated CNY 1.15b in revenue while keeping the reported net loss to just CNY 5.94m. For a company still widely viewed as an early stage drug developer, that gap between modest share price and emerging profit profile is what matters. Investors now have to...

CARsgen Therapeutics Holdings closed at HK$14.90 today after a choppy few months in which the stock has slipped about 15% over 90 days. Yet behind the weak chart, the latest half year numbers point to one issue that matters most for you as a shareholder. The balance sheet and valuation strain is now the key tension between short term sentiment and long term promise. Revenue for the first half of 2026 came in at ¥61.9 million, while the company still reported a net loss of ¥66.7 million. With...

PAX Global Technology stock closed at HK$3.69 on Wednesday, leaving recent short term returns slightly in the red even as the latest earnings tell a different story. The headline is simple: profitability looks healthier. Trailing 12 month net profit margin sits at 14% and earnings over that period are described as high quality. The market still prices the stock on a P/E of 4.4x, well below sector averages, which keeps the longer term valuation debate wide open. Appreciating the 14% net profit...

Huaneng Power International stock has been sliding for weeks and came into this earnings release already under pressure, with the share price down about 17% over 3 months. The results have now handed investors a different kind of discomfort. Quarterly basic earnings per share fell to ¥0.073581 and net income dropped to ¥990.4m, which is a sharp squeeze compared with the prior quarters in this cycle. The market is reacting to a stock that screens cheap on a 7.8x P/E and carries an 8.64%...

FriendTimes closed at HK$0.39 on Wednesday, leaving the stock down roughly 3% over the past week and month and about 13% over three months. That muted price suggests short term fatigue. The headline from these results is different. Trailing 12 month earnings almost doubled year on year and net profit margin moved into double digits, helped by a sizeable one off gain of CN¥117.6m. The immediate share price reaction indicates that traders are cautious. The earnings mix indicates that the real...

Dekon Food and Agriculture Group shares closed at HK$53.05, with recent returns drifting only slightly in either direction. The calm price action sits awkwardly against a headline result that flips the story from profit to loss. For the first half of 2026 Dekon reported about ¥10,088.7m in revenue but moved to a net loss of roughly ¥1,158.8m. For a food producer where earnings quality and cash resilience matter, this profit squeeze is a key focus for investors. The question now is whether the...

Ping An Healthcare and Technology has been treated like a high growth digital health platform with a valuation to match, yet the stock closed at HK$7.13 on 19 August, with the past three months delivering a decline of about 23%. Against that weaker share price, the H1 2026 headline is simple: the company stayed solidly profitable with basic earnings per share of ¥0.10 and net income of ¥219.3 million, while trailing net profit margin held at 8.5%. The market reaction and the income statement...

Weimob stock closed at HK$1.11 on Wednesday, capping a weak run with the share price down about 10% over the past week and about 15% over three months. The headline from these H1 2026 results is not a revenue miss or surprise beat. It is the strain of ongoing losses sitting on top of a valuation that already prices the company at about 2.3x sales, above the Hong Kong software peer group. For short term traders that combination stings. For long term investors the key question is whether the...

Shanghai Seer Intelligent Technology’s stock has barely budged over the past week, yet the earnings story is anything but flat. The company is still loss making, with a basic H1 2026 loss per share of ¥0.38, but revenue reached ¥264.4m and it continues to carry a premium P/S of 11.3x against a far lower Hong Kong machinery industry average. The market’s calm reaction contrasts with a report that sharpens a key question for you: is this high revenue growth story with ongoing losses worth such...

Qinqin Foodstuffs Group (Cayman) came into this earnings day with a stock that has drifted, down about 13% over the past week and roughly 14% over three months, despite trading near a discounted cash flow fair value estimate far above the current HK$0.90 price. The headline from H1 2026 is simple: the company stayed modestly profitable, with basic earnings per share of CNY 0.007 and net income of CNY 4.937 million, yet the trailing twelve month picture still shows a loss and an uncovered...

Xiaomi stock closed at HK$27.44 after the Q2 2026 print, leaving investors to weigh a flat near term share price against earnings that were all about profit quality. The headline was simple: revenue reached RMB 108.9b while net income excluding extra items came in at RMB 9.5b. However, the real story sat in a group gross margin close to 19.8%. For a consumer electronics and smart devices company that lives or dies on hardware economics, that margin outcome will matter more to your view on...

Tsaker New Energy Tech stock has quietly climbed 15.8% over the past month, yet today’s headline is not the share price. The real story is a sharp swing back into profit in the chemicals business. Half year 2026 basic earnings per share landed at C¥0.10 on revenue of C¥1,413.1m, a very different picture from the loss reported in the second half of 2025. For a company that carries a five year record of steep earnings decline and a P/E below sector averages, this latest profitable half raises a...

China Jinmao Holdings Group (SEHK:817) has released unaudited contracted sales data for July 2026, giving investors a fresh look at monthly performance and year to date progress across its major development projects. See our latest analysis for China Jinmao Holdings Group. At the latest share price of HK$1.465, China Jinmao Holdings Group has a year to date share price return of 19.11%, while the 1 year total shareholder return has declined 4.92%. This suggests that shorter term momentum has...

Tingyi (Cayman Islands) Holding (SEHK:322) reported higher sales and net income for the half year to June 30, 2026. This points to improved operating performance and gives investors fresh earnings data to assess. See our latest analysis for Tingyi (Cayman Islands) Holding. The latest results from Tingyi (Cayman Islands) Holding come as momentum in the stock has been building, with an 18.1% 1 month share price return and a 35.9% 1 year total shareholder return, suggesting investors are...

Amidst a backdrop of easing inflation concerns and mixed performances across major indices, global markets continue to navigate a complex landscape. For investors seeking unique opportunities, penny stocks—often representing smaller or newer companies—remain an intriguing area of exploration. Despite being considered a throwback term, these stocks can offer growth potential at lower price points when paired with solid financials and strong fundamentals.

Everest Medicines Limited has released its interim results for the half year ended June 30, 2026, reporting CNY 1,147.84 million in sales versus CNY 446.12 million a year earlier and a sharply reduced net loss of CNY 5.94 million compared with CNY 249.79 million. This swing toward near break-even, with basic and diluted loss per share narrowing from CNY 0.77 to CNY 0.02, suggests operating progress that could meaningfully influence how investors view the company’s path to...

CSPC Pharmaceutical Group recently reported three developments: U.S. FDA approval to begin clinical trials for its mpox mRNA vaccine, a US$10,000,000 milestone payment from AstraZeneca tied to their small-molecule collaboration, and a joint venture with AstraZeneca to build a biologics manufacturing facility in Shijiazhuang, China. Together, these moves expand CSPC’s innovative vaccine and drug pipeline while pushing its manufacturing and quality systems further onto the global stage. We’ll...

Unitree Robotics’ huge Shanghai IPO debut has thrown a spotlight on Chinese robotics and automation stocks, as investors look for ways to tap into this wave of excitement and policy support. That surge in attention can quickly reshape how related companies are viewed and valued, which creates both opportunity and risk. This article walks through 3 stocks exposed to the same news, to help you decide which deserve a closer look. The 3 stocks below are just a small sample of what this Chinese...

Half year earnings put Uni-President China Holdings in focus Uni-President China Holdings (SEHK:220) has come into focus after reporting half year earnings to June 30, 2026, with sales of CNY 17,320.97 million and net income of CNY 1,402.35 million. See our latest analysis for Uni-President China Holdings. At a share price of HK$7.905, Uni-President China Holdings has seen a 3.88% 1 month share price return and a 66.55% 3 year total shareholder return, suggesting long term momentum despite a...

We feel now is a pretty good time to analyse Minieye Technology Co., Ltd's ( HKG:2431 ) business as it appears the...

Chongqing Machinery & Electric Co., Ltd. ( HKG:2722 ), is not the largest company out there, but it received a lot of...

The recent price decline of 12% in Huicheng International Holdings Limited's ( HKG:1146 ) stock may have disappointed...